sulfasalazine has been researched along with Acute Symptom Flare in 5 studies
Sulfasalazine: A drug that is used in the management of inflammatory bowel diseases. Its activity is generally considered to lie in its metabolic breakdown product, 5-aminosalicylic acid (see MESALAMINE) released in the colon. (From Martindale, The Extra Pharmacopoeia, 30th ed, p907)
sulfasalazine : An azobenzene consisting of diphenyldiazene having a carboxy substituent at the 4-position, a hydroxy substituent at the 3-position and a 2-pyridylaminosulphonyl substituent at the 4'-position.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (60.00) | 24.3611 |
| 2020's | 2 (40.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sukharomana, M | 1 |
| Charuvanij, S | 1 |
| Lillegraven, S | 1 |
| Paulshus Sundlisæter, N | 1 |
| Aga, AB | 1 |
| Sexton, J | 1 |
| Olsen, IC | 1 |
| Fremstad, H | 1 |
| Spada, C | 1 |
| Madland, TM | 1 |
| Høili, CA | 1 |
| Bakland, G | 1 |
| Lexberg, Å | 1 |
| Hansen, IJW | 1 |
| Hansen, IM | 1 |
| Haukeland, H | 1 |
| Ljoså, MA | 1 |
| Moholt, E | 1 |
| Uhlig, T | 1 |
| Solomon, DH | 1 |
| van der Heijde, D | 1 |
| Kvien, TK | 1 |
| Haavardsholm, EA | 1 |
| Deschamps, A | 1 |
| Samain, A | 1 |
| Carvalho, P | 1 |
| Courville, P | 1 |
| Levesque, H | 1 |
| Musette, P | 1 |
| Joly, P | 1 |
| Hissink Muller, P | 1 |
| Brinkman, DMC | 1 |
| Schonenberg-Meinema, D | 1 |
| van den Bosch, WB | 1 |
| Koopman-Keemink, Y | 1 |
| Brederije, ICJ | 1 |
| Bekkering, PW | 1 |
| Kuijpers, TW | 1 |
| Van Rossum, M | 1 |
| van Suijlekom-Smit, LWA | 1 |
| van den Berg, JM | 1 |
| Boehringer, S | 1 |
| Allaart, CF | 1 |
| Ten Cate, R | 1 |
| Lian, BS | 1 |
| Busmanis, I | 1 |
| Lee, HY | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| REmission in Rheumatoid Arthritis - Assessing WIthrawal of Disease-modifying Antirheumatic Drugs in a Non-inferiority Design[NCT01881308] | Phase 4 | 320 participants (Actual) | Interventional | 2013-06-17 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 trials available for sulfasalazine and Acute Symptom Flare
| Article | Year |
|---|---|
Effect of Half-Dose vs Stable-Dose Conventional Synthetic Disease-Modifying Antirheumatic Drugs on Disease Flares in Patients With Rheumatoid Arthritis in Remission: The ARCTIC REWIND Randomized Clinical Trial.
Topics: Adult; Aged; Antirheumatic Agents; Arthritis, Rheumatoid; Dose-Response Relationship, Drug; Drug The | 2021 |
Treat to target (drug-free) inactive disease in DMARD-naive juvenile idiopathic arthritis: 24-month clinical outcomes of a three-armed randomised trial.
Topics: Adolescent; Antirheumatic Agents; Arthritis, Juvenile; Blood Sedimentation; Child; Child, Preschool; | 2019 |
3 other studies available for sulfasalazine and Acute Symptom Flare
| Article | Year |
|---|---|
Outcomes of intraarticular triamcinolone acetonide injection in children with non-systemic juvenile idiopathic arthritis.
Topics: Arthritis, Juvenile; Child; Humans; Injections, Intra-Articular; Retrospective Studies; Sulfasalazin | 2023 |
A familial mediterranean fever flare induced by a drug reaction with eosinophilia and systemic symptoms.
Topics: Adult; Antirheumatic Agents; Colchicine; Drug Hypersensitivity Syndrome; Familial Mediterranean Feve | 2018 |
Relapsing Course of Sulfasalazine-Induced Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) Complicated by Alopecia Universalis and Vitiligo.
Topics: Alopecia; Antirheumatic Agents; Arthritis, Rheumatoid; Biopsy; Cyclosporine; Dermatologic Agents; Dr | 2018 |